BMRN
Price
$84.05
Change
-$7.15 (-7.84%)
Updated
Apr 25, 1:18 PM EST
96 days until earnings call
INCY
Price
$51.03
Change
-$0.71 (-1.37%)
Updated
Apr 25, 1:32 PM EST
5 days until earnings call
Ad is loading...

Analysis and predictions BMRN vs INCY

Header iconBMRN vs INCY Comparison
Open Charts BMRN vs INCYBanner chart's image
BioMarin Pharmaceutical
Price$84.05
Change-$7.15 (-7.84%)
Volume$4.02K
CapitalizationN/A
Incyte
Price$51.03
Change-$0.71 (-1.37%)
Volume$500
CapitalizationN/A
View a ticker or compare two or three
BMRN vs INCY Comparison Chart

Loading...

BMRNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
INCYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BMRN vs. INCY commentary
Apr 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Hold and INCY is a Hold.

COMPARISON
Comparison
Apr 25, 2024
Stock price -- (BMRN: $91.20 vs. INCY: $51.74)
Brand notoriety: BMRN: Not notable vs. INCY: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 113% vs. INCY: 89%
Market capitalization -- BMRN: $17.31B vs. INCY: $11.62B
BMRN [@Biotechnology] is valued at $17.31B. INCY’s [@Biotechnology] market capitalization is $11.62B. The market cap for tickers in the [@Biotechnology] industry ranges from $567.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileINCY’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • INCY’s FA Score: 0 green, 5 red.
According to our system of comparison, INCY is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 6 TA indicator(s) are bullish while INCY’s TA Score has 2 bullish TA indicator(s).

  • BMRN’s TA Score: 6 bullish, 5 bearish.
  • INCY’s TA Score: 2 bullish, 2 bearish.
According to our system of comparison, BMRN is a better buy in the short-term than INCY.

Price Growth

BMRN (@Biotechnology) experienced а +0.81% price change this week, while INCY (@Biotechnology) price change was -1.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.53%. For the same industry, the average monthly price growth was -8.76%, and the average quarterly price growth was +1259.25%.

Reported Earning Dates

BMRN is expected to report earnings on Jul 30, 2024.

INCY is expected to report earnings on Jul 30, 2024.

Industries' Descriptions

@Biotechnology (-1.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BMRN with price predictions.
OPEN
A.I.dvisor published
a Summary for INCY with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BMRN($17.3B) has a higher market cap than INCY($11.6B). BMRN has higher P/E ratio than INCY: BMRN (104.83) vs INCY (19.52). BMRN YTD gains are higher at: -5.414 vs. INCY (-17.598).
BMRNINCYBMRN / INCY
Capitalization17.3B11.6B149%
EBITDAN/AN/A-
Gain YTD-5.414-17.59831%
P/E Ratio104.8319.52537%
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
BMRN vs INCY: Fundamental Ratings
BMRN
INCY
OUTLOOK RATING
1..100
1752
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8664
PRICE GROWTH RATING
1..100
5164
P/E GROWTH RATING
1..100
7694
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INCY's Valuation (67) in the Biotechnology industry is in the same range as BMRN (85). This means that INCY’s stock grew similarly to BMRN’s over the last 12 months.

INCY's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as BMRN (100). This means that INCY’s stock grew similarly to BMRN’s over the last 12 months.

INCY's SMR Rating (64) in the Biotechnology industry is in the same range as BMRN (86). This means that INCY’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's Price Growth Rating (51) in the Biotechnology industry is in the same range as INCY (64). This means that BMRN’s stock grew similarly to INCY’s over the last 12 months.

BMRN's P/E Growth Rating (76) in the Biotechnology industry is in the same range as INCY (94). This means that BMRN’s stock grew similarly to INCY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRNINCY
RSI
ODDS (%)
Bearish Trend 2 days ago
55%
Bullish Trend 2 days ago
54%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
66%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
64%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
64%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
61%
Bearish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 3 days ago
62%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
58%
Bearish Trend 3 days ago
67%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
59%
Aroon
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
63%
View a ticker or compare two or three
Ad is loading...
BMRNDaily Signal changed days agoGain/Loss if shorted
 
Show more...
INCYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTAK0.570.12
+26.18%
Catheter Precision
AGCO118.691.24
+1.06%
AGCO Corp
SHOT1.650.02
+0.92%
Safety Shot
TAST9.51N/A
N/A
Carrols Restaurant Group
HNI42.73-0.64
-1.48%
HNI Corp

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with SRPT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
-0.93%
SRPT - BMRN
45%
Loosely correlated
+6.09%
FOLD - BMRN
43%
Loosely correlated
-1.59%
AXON - BMRN
42%
Loosely correlated
+0.28%
FGEN - BMRN
41%
Loosely correlated
-8.01%
NTLA - BMRN
39%
Loosely correlated
-1.67%
More

INCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INCY has been loosely correlated with EXEL. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if INCY jumps, then EXEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCY
1D Price
Change %
INCY100%
+0.17%
EXEL - INCY
45%
Loosely correlated
+1.80%
JAZZ - INCY
40%
Loosely correlated
-1.23%
AXON - INCY
39%
Loosely correlated
+0.28%
TVTX - INCY
37%
Loosely correlated
-5.05%
UTHR - INCY
37%
Loosely correlated
+1.08%
More